Technical Analysis for ONCY - Oncolytics Biotech Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| C | 1.05 | 0.48% | 0.01 |
ONCY closed down 3.7 percent on Wednesday, April 17, 2024, on 44 percent of normal volume. The stock fell below its 50 day moving average, damaging its intermediate-term outlook by crossing under that important trendline. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
Earnings due: May 3
*** please verify all earnings dates ***| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Fell Below 50 DMA | Bearish | 0.48% | |
| MACD Bearish Signal Line Cross | Bearish | 0.48% | |
| Stochastic Reached Oversold | Weakness | 0.48% | |
| Oversold Stochastic | Weakness | 0.48% | |
| Crossed Above 50 DMA | Bullish | -3.24% | |
| Hammer Candlestick | Bullish | -3.24% | |
| Non-ADX 1,2,3,4 Bullish | Bullish Swing Setup | -3.24% | |
| Fell Below 20 DMA | Bearish | -1.42% | |
| Fell Below 50 DMA | Bearish | -1.42% | |
| 180 Bearish Setup | Bearish Swing Setup | -1.42% |
| Alert | Time |
|---|---|
| Possible NR7 | 9 minutes ago |
| 60 Minute Opening Range Breakout | about 1 hour ago |
| Up 1% | about 1 hour ago |
| Down 1% | about 4 hours ago |
| 20 DMA Resistance | 1 day ago |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/03/2024
Oncolytics Biotech Inc is a development stage biopharmaceutical company. It is engaged in the discovery and development of pharmaceutical products for the treatment of cancer that have not been successfully treated with conventional therapeutics.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Biopharmaceutical Cancer Life Sciences Treatment Of Cancer Pharmaceutical Products Oncolytics Biotech Synbio
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Biopharmaceutical Cancer Life Sciences Treatment Of Cancer Pharmaceutical Products Oncolytics Biotech Synbio
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 3.3942 |
| 52 Week Low | 0.883 |
| Average Volume | 409,130 |
| 200-Day Moving Average | 1.67 |
| 50-Day Moving Average | 1.06 |
| 20-Day Moving Average | 1.08 |
| 10-Day Moving Average | 1.12 |
| Average True Range | 0.08 |
| RSI (14) | 43.82 |
| ADX | 16.54 |
| +DI | 15.88 |
| -DI | 19.31 |
| Chandelier Exit (Long, 3 ATRs) | 1.06 |
| Chandelier Exit (Short, 3 ATRs) | 1.20 |
| Upper Bollinger Bands | 1.19 |
| Lower Bollinger Band | 0.97 |
| Percent B (%b) | 0.31 |
| BandWidth | 20.37 |
| MACD Line | 0.01 |
| MACD Signal Line | 0.01 |
| MACD Histogram | -0.0046 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 1.13 | ||||
| Resistance 3 (R3) | 1.13 | 1.11 | 1.12 | ||
| Resistance 2 (R2) | 1.11 | 1.08 | 1.11 | 1.11 | |
| Resistance 1 (R1) | 1.07 | 1.07 | 1.06 | 1.07 | 1.10 |
| Pivot Point | 1.05 | 1.05 | 1.04 | 1.05 | 1.05 |
| Support 1 (S1) | 1.01 | 1.02 | 1.00 | 1.01 | 0.98 |
| Support 2 (S2) | 0.99 | 1.01 | 0.99 | 0.97 | |
| Support 3 (S3) | 0.95 | 0.99 | 0.97 | ||
| Support 4 (S4) | 0.95 |
